Apheresis room with four reclining treatment chairs beside apheresis machines

Blood Purification

Apheresis therapies

Apheresis is a group of blood purification procedures. Blood leaves the body through one line, a machine removes one component of the plasma (autoantibodies, immune complexes, lipoproteins, fibrinogen or inflammatory proteins), and the rest returns through a second line. St. George Hospital runs five methods on its ward, and your laboratory findings decide which one you receive.

Apheresis

Treatments in this group

  • TherapyH.E.L.P. apheresis

    HELP apheresis (H.E.L.P., Heparin-induced Extracorporeal LDL Precipitation) is a blood filtration therapy that removes LDL cholesterol, lipoprotein(a), fibrinogen …

  • TherapyImmunoadsorption

    Immunoadsorption is an apheresis procedure that removes antibodies from the plasma.

  • TherapyTherapeutic plasma exchange

    Therapeutic plasma exchange (TPE) removes and replaces the liquid part of your blood while returning the blood cells.

  • TherapyRed blood cell exchange

    Red blood cell exchange (erythrocytapheresis) removes the patient's red blood cells with an apheresis machine and replaces them with matched donor red cells in the …

  • TherapyDouble cascade filtration

    Double cascade filtration is a two-stage plasma filtration technique that removes large proteins such as autoantibodies, immune complexes and fibrinogen while …

  • Treatment program for international patientsLong COVID and ME/CFS program

    Many patients with Long COVID or ME/CFS have normal results in standard tests and still cannot manage daily life.

What it is

What is apheresis?

Apheresis (pronounced af-uh-REE-sis, from the Greek aphairesis, taking away) draws blood from a vein, passes it through a device that removes one component of the plasma, and returns it to the body in a closed circuit. Blood banks use the same technique to collect plasma or platelets from healthy donors.

The device separates plasma from blood cells by centrifuge or membrane, and what happens to the plasma next defines the method. Only a small volume of blood is outside the body at any moment. For Long COVID and ME/CFS, apheresis is the center of the Long COVID and ME/CFS apheresis program, a stay of two to three weeks. In chronic Lyme disease it is one module of the Lyme disease program.

Blood purification procedures compared

  • H.E.L.P. apheresis

    What it removes
    LDL, lipoprotein(a), fibrinogen, inflammatory proteins
    Replacement fluid
    None
    One session
    2 to 3 hours
    Typical use here
    Long COVID, chronic Lyme disease, lipid disorders
    More about H.E.L.P. apheresis
  • Immunoadsorption

    What it removes
    Immunoglobulins, in particular IgG autoantibodies
    Replacement fluid
    None
    One session
    2 to 4 hours
    Typical use here
    ME/CFS and post-COVID ME/CFS with autoantibodies, autoimmune disease
    More about Immunoadsorption
  • Double cascade filtration

    What it removes
    Large proteins: IgM, IgG, immune complexes, fibrinogen
    Replacement fluid
    Usually none
    One session
    2 to 3 hours
    Typical use here
    Hyperviscosity, cryoglobulinemia, immune complex disease
    More about Double cascade filtration
  • Therapeutic plasma exchange

    What it removes
    The whole plasma
    Replacement fluid
    Albumin or donor plasma
    One session
    2 to 3 hours
    Typical use here
    Autoimmune neurology, high inflammatory load
    More about Therapeutic plasma exchange

Red blood cell exchange (1.5 to 3 hours) swaps the red cells themselves. Your physician chooses the method from your laboratory findings.

Who it is for

What conditions is apheresis used for?

Apheresis is used when a measurable substance in the plasma is part of the disease and the body is not clearing it. Medication can blunt what that substance does; apheresis takes it out of the blood. The finding that drives your symptoms decides the method.

  • Long COVID and ME/CFS with raised fibrinogen, lipoproteins or autoantibodies against adrenergic and muscarinic receptors
  • Chronic Lyme disease and co-infections with a high inflammatory load or circulating immune complexes
  • Autoimmune conditions with harmful antibodies, in neurology, nephrology and cardiology
  • Lipid disorders, above all raised lipoprotein(a) and familial hypercholesterolemia
  • Red cell disease and red cell parasites (red blood cell exchange)

Who it is not for

Patients with unstable circulation, active bleeding, a heparin allergy (for heparin-based methods) or veins that cannot carry two lines. A physician checks these points on the first day.

Is apheresis right for you?

Send the International Office a short history; the initial inquiry is free of charge. The Office then requests your records. After the medical review you learn whether apheresis belongs in your plan, which method and how many sessions.

How a session runs

Two to four hours, depending on the method and the plasma volume.

  1. Before

    on the ward

    A nurse checks blood pressure, pulse and clotting values and places one line in each arm. You sit in a reclining chair.

  2. During

    2 to 4 hours

    The machine runs continuously and a nurse stays in the room. If your lips tingle or your arm feels cool, the flow is slowed.

  3. Afterwards

    The puncture sites are bandaged and you rest before returning to your room. The raised markers are measured again before discharge.

Some patients are tired that evening. The spacing of the next session is in your written plan.

Evidence and safety

The evidence is strong for the standard indications, such as lipid disorders and Guillain-Barré syndrome. For Long COVID and ME/CFS it comes from cohort studies, so apheresis there is an individual treatment attempt. Side effects are mostly mild.

Read the studies and the safety data

The evidence is strong for the standard indications. H.E.L.P. apheresis has lowered LDL cholesterol and lipoprotein(a) in patients with severe lipid disorders since the 1990s (Lees et al., 1996), and the German Lipoprotein Apheresis Registry has followed those patients for more than a decade (Schettler et al., 2024). Therapeutic plasma exchange in Guillain-Barré syndrome is supported by randomized trials pooled in a Cochrane review (Chevret et al., 2017). The American Society for Apheresis grades every indication in its guideline, updated in 2023 (Connelly-Smith et al., 2023).

For Long COVID and ME/CFS the evidence is emerging. Fibrin amyloid microclots and platelet pathology have been described in Long COVID plasma (Pretorius et al., 2022). Dr. Beate Jaeger, Chief Physician for internal and laboratory medicine at the hospital, described the rationale for H.E.L.P. apheresis in acute and chronic COVID-19 (Jaeger et al., 2022); a 2023 study found that clinical improvement after therapeutic apheresis in Long COVID went together with lower autoantibodies, lipids and inflammatory markers (Achleitner et al., 2023); and a prospective cohort of post-COVID ME/CFS patients with β2-adrenergic receptor autoantibodies was treated with repeated immunoadsorption (Stein et al., 2025). These are cohort and observational studies without a control group; they show the mechanism and the direction, and a randomized trial has yet to settle the question. Apheresis for these indications is an individual treatment attempt, decided with the patient after medical consultation and measured before and after.

Safety is documented in registries. The World Apheresis Association registry, which collects procedures across many centers, reports that side effects are mostly mild: tingling from the citrate or heparin, a drop in blood pressure, bruising at the puncture site (Vrielink et al., 2023). A 2020 series of plasma exchange and immunoadsorption in neuroinflammatory disease found both procedures well tolerated under monitoring (Dorst et al., 2020). On our ward a physician is on site and a nurse stays in the room for every session.

On the ward

  • Gloved hands operating a laboratory blood analyser
    The hospital laboratory · Clinicum St. Georg
  • A therapy room with two treatment couches under round ceiling lights
    A therapy room · Clinicum St. Georg
  • A patient room with a wooden-framed hospital bed, a chair and a bright window
    A patient room · Clinicum St. Georg

The hospital laboratory runs the admission work-up that decides the method.

In the program

How apheresis fits into your program

Apheresis removes what is circulating today. It does not stop the body from producing more, so it is rarely used alone. In the Long COVID and ME/CFS program the sessions fall between the laboratory work-up at admission and the second measurement in week two, with infusion and immune therapies around them. In the Lyme program H.E.L.P. apheresis runs alongside whole-body hyperthermia and antimicrobial treatment.

Costs depend on the method and the number of sessions: a package price plus individual add-ons, listed in a written, itemized cost overview before you travel. Costs and insurance

FREQUENTLY ASKED QUESTIONS

Common questions about apheresis

What is apheresis?

Apheresis is a group of procedures in which blood is drawn from a vein, passed through a device that removes a defined component of the plasma, and returned to the body in a closed circuit. The word comes from the Greek aphairesis, taking away. Therapeutic apheresis treats a patient; donor apheresis collects platelets or plasma from a healthy donor.

How does apheresis work?

A line in one arm carries blood into the machine, which separates plasma from blood cells by centrifuge or membrane. The plasma is then filtered, precipitated or passed over an adsorption column, depending on the method. The cleaned plasma and the cells return through a second line. The circuit runs continuously, so only a small volume is outside the body at any moment.

Which apheresis methods does St. George Hospital offer?

Five: H.E.L.P. apheresis, immunoadsorption, therapeutic plasma exchange, red blood cell exchange and double cascade filtration. Each has its own page describing what the procedure removes, how a session runs and what the evidence shows.

Which conditions is apheresis used for?

At St. George Hospital apheresis is used in Long COVID and ME/CFS, in chronic Lyme disease, in autoimmune conditions with circulating autoantibodies, and in lipid disorders such as high lipoprotein(a). The method follows the finding: fibrinogen and lipoproteins point to H.E.L.P. apheresis, autoantibodies to immunoadsorption, a broad inflammatory load to plasma exchange.

How long does apheresis take?

One session takes about 2 to 3 hours for H.E.L.P. apheresis and 2 to 4 hours for immunoadsorption, including the time to place the lines and a short rest afterwards. Most patients need several sessions; the written treatment proposal states the planned number and the spacing between them.

Is apheresis painful?

The needles are the only part most patients feel: one line in each arm, placed by a nurse. During the session you sit in a reclining chair and can read or sleep. Tingling around the lips, a cool feeling in the arm or brief lightheadedness can occur; the nurse slows the flow and it passes.

Is apheresis safe?

Apheresis is an established hospital procedure with a known risk profile. The most frequent side effects are tingling from the anticoagulant, a drop in blood pressure and bruising at the puncture sites. Serious events are rare in registry data when the procedure is run by trained staff with continuous monitoring, which is how it is done here.

How do you decide which type of apheresis I need?

From the laboratory findings. The work-up at the start of your stay measures autoantibodies, lipids, fibrinogen and inflammatory markers. A physician reads them with your history and names the method, the number of sessions and what will be measured again afterwards. The plan is set before you travel, after the medical review of your records and a video call.

References

  1. Treatment of hypercholesterolemia with heparin-induced extracorporeal low-density lipoprotein precipitation (HELP). J Clin Apher 1996. PMID 8915817
  2. The German Lipoprotein Apheresis Registry: Summary of the eleventh annual report. Atherosclerosis 2024. PMID 39342791
  3. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev 2017. PMID 28241090
  4. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice: The Ninth Special Issue. J Clin Apher 2023. PMID 37017433
  5. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/PASC. Cardiovasc Diabetol 2022. PMID 35933347
  6. The potential of heparin-induced extracorporeal LDL/fibrinogen precipitation (H.E.L.P.)-apheresis for patients with severe acute or chronic COVID-19. Front Cardiovasc Med 2022. PMID 36304538
  7. Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis. Mol Psychiatry 2023. PMID 37131073
  8. Efficacy of repeated immunoadsorption in patients with post-COVID ME/CFS and elevated β2-adrenergic receptor autoantibodies: a prospective cohort study. Lancet Reg Health Eur 2025. PMID 39759581
  9. The world apheresis association registry, 2023 update. Transfus Apher Sci 2023. PMID 37827962
  10. Safety and Tolerability of Plasma Exchange and Immunoadsorption in Neuroinflammatory Diseases. J Clin Med 2020. PMID 32899499

From the journal

Reading on Apheresis and blood purification

  1. Apheresis · · 7 min read

    Apheresis for long COVID: How blood filtering works and what the evidence shows

    Apheresis is a medical procedure in which blood is drawn from the patient, passed through a specialized filter that selectively removes harmful substances, and returned to the body. In the context of long COVID, apheresis has emerged as one of the most promising

All articles on Apheresis and blood purification

Send a free inquiry

The initial inquiry is free of charge. The International Office reviews your message and your case directly and gets back to you.

Hours
Mon–Thu 08:00–17:00, Fri 08:00–14:00 German time (CET/CEST); in the US Mon–Thu 2–11 a.m. ET, Fri 2–8 a.m. ET.

Munich Airport (MUC), about 60 minutes by car.

CallSend a free inquiry